Nanocarriers based novel and effective drug delivery system.
Carbon nanotubes
Drug delivery
Inorganic
Nanocarriers
Organic
Quantum dots
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
05 Feb 2023
05 Feb 2023
Historique:
received:
15
09
2022
revised:
12
12
2022
accepted:
27
12
2022
pubmed:
2
1
2023
medline:
14
3
2023
entrez:
1
1
2023
Statut:
ppublish
Résumé
Nanotechnology has ultimately come into the domain of drug delivery. Nanosystems for delivery of drugs are promptly emerging science utilizing different nanoparticles as carriers. Biocompatible and stable nanocarriers are novel diagnosis tools or therapy agents for explicitly targeting locates with controllable way. Nanocarriers propose numerous advantages to treat diseases via site-specific as well as targeted delivery of particular therapeutics. In recent times, there are number of outstanding nanocarriers use to deliver bio-, chemo-, or immuno- therapeutic agents to obtain effectual therapeutic reactions and to minimalize unwanted adverse-effects. Nanoparticles possess remarkable potential for active drug delivery. Moreover, conjugation of drugs with nanocarriers protects drugs from metabolic or chemical modifications, through their way to targeted cells and hence increased their bioavailability. In this review, various systems integrated with different types of nanocarriers (inorganic. organic, quantum dots, and carbon nanotubes) having different compositions, physical and chemical properties have been discussed for drug delivery applications.
Identifiants
pubmed: 36587775
pii: S0378-5173(22)01125-5
doi: 10.1016/j.ijpharm.2022.122570
pii:
doi:
Substances chimiques
Nanotubes, Carbon
0
Pharmaceutical Preparations
0
Drug Carriers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
122570Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.